Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2018

Jan 3, 2018

35221_dirs_2018-01-03_3298df6d-0cec-4205-8e84-f0ec29655d7d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2017-12-21

Reporting Person: DeGuzman Brian J. (Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-21 Common Stock J 645346 Acquired 645346 Indirect
2017-12-21 Common Stock J 645346 Disposed 0 Indirect

Footnotes

F1: Pro rata distribution from HCFP/Capital Partners III LLC, of which the trust is a non-managing member.

F2: Contribution to Pavilion Venture Partners LLC, of which the trust is a non-managing member.